Inovio Pharmaceuticals
INO
#9026
Rank
HK$1.53 B
Marketcap
HK$14.83
Share price
213.75%
Change (1 day)
-23.67%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -HK$14.30

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$14.36. In 2025 the company made an earnings per share (EPS) of -HK$14.20 an increase over its 2024 EPS that were of -HK$30.99.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$14.300.71%
2025-HK$14.20-54.18%
2024-HK$30.99-35.14%
2023-HK$47.78-56.62%
2022-HK$110.16-19.54%
2021-HK$136.9235.9%
2020-HK$100.74-11.57%
2019-HK$113.9315.24%
2018-HK$98.86-2.78%
2017-HK$101.696.93%
2016-HK$95.10134.88%
2015-HK$40.49-29.51%
2014-HK$57.43-57.34%
2013-HK$134.64146.55%
2012-HK$54.6120.83%
2011-HK$45.19-29.41%
2010-HK$64.02-48.48%
2009-HK$124.2810%
2008-HK$112.9811.11%
2007-HK$101.69-41.3%
2006-HK$173.24-66.91%
2005-HK$523.50110.61%
2004-HK$248.57-61.63%
2003-HK$647.78186.67%
2002-HK$225.97
2001N/A-100%
2000-HK$180.78-63.64%
1999-HK$497.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.53-577.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$52.26-463.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$20.40 42.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-169.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$25.09-274.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-HK$26.13 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA